As Chief Executive Officer for CounterPath, David Karp manages accounting, finance, planning and investor relations, allowing the company to better execute on its strategic and financial goals.
David brings more than twenty years of corporate finance and operating experience to CounterPath. While VP Investment Banking at BMO Nesbitt Burns, David raised hundreds of millions of dollars through equity financings and managed a number of merger and acquisitions. Previously, David was CFO for Chemokine Therapeutics Corp. where he was instrumental in the company's successful initial public offering and follow-on financing. Prior to Chemokine, David was CFO for Neuro Discovery Inc. (Allon Therepeutics Inc.), a publicly traded investment company focused on biotechnology investing.
David holds a Bachelor of Science degree in Mechanical Engineering from the University of Waterloo in Ontario, an MBA from the Ivey School of Business in London, Ontario, and is a CFA Charterholder and professional engineer.